Sexual Problems May Arise After Breast Cancer

THURSDAY, Sept. 23 (HealthDay News) -- Sexual problems are common among breast cancer survivors, according to new research.

In a study of about 1,000 women treated for breast cancer, nearly three-quarters of those younger than 70 who had a partner reported sexual difficulties, such as loss of desire or reduced sexual activity, two years after diagnosis.

"We see a large number of women who tell us this is an issue," said study co-author Mary Panjari, a researcher at Monash University Medical School in Prahran, Australia. "The finding that 70 percent had sexual problems after diagnosis and initial treatment ... puts numbers to the anecdotal findings," she said. It also echoes previous research.

The study, published online Sept. 23 in the Journal of Sexual Medicine, has broad implications given the increasing numbers of breast cancer survivors, experts say.

Panjari and her colleagues polled 1,684 women in Australia within 12 months of their diagnosis of invasive breast cancer. They asked the women to complete questionnaires annually for five years on their breast cancer treatment, partner status, body image, menopausal symptoms and sexual functioning.

The researchers excluded from the analysis women with active disease, those widowed or without a partner and those 70 and older, reasoning they would have less interest in sex or not be distressed by the lack of it.

That left them with 1,011 women, but data was missing on 17, bringing the number down to 994. Of these, 287 had no sexual problems, but 707 did.

More than 80 percent of the women surveyed reported their sex life had been satisfactory before breast cancer.

Eighty percent who reported sexual problems post-diagnosis also had menopausal symptoms, such as hot flashes and night sweats, which have been linked in other research to decreased sexual function.

Cancer medications and body image also contributed to sexual inhibition, it appears. "Women on aromatase inhibitors were 2.5 times more likely to report sexual function problems if they also had body image issues," Panjari said. "So having body image issues exacerbates sexual problems for women on aromatase inhibitors."

Aromatase inhibitors, a common treatment, are substances that block tumor growth in estrogen-sensitive breast cancers by lowering the amount of estrogen in the body.

Declining sexuality following breast cancer is "an important problem," said Dr. Christine Derzko, an associate professor of obstetrics and gynecology and internal medicine at St. Michael's Hospital at the University of Toronto, Canada, who has written on the topic.

"Drawing attention to this issue is important," she added. "Giving women permission to talk about sexuality is important."

Body image and medications are common hurdles, she noted. The aromatase inhibitors have been linked to vaginal dryness, the Monash researchers reported, and that can lead to painful intercourse, which affects the mechanics of sex, Derzko said.

But women should not discontinue the aromatase inhibitor on their own, Panjari said.

In addition, scars from breast surgery or radiation-induced skin disturbances can remind women of the cancer, Derzko said. Many women worry it will also remind their partner of their illness.

But there's help, these experts added. Derzko said a woman's physician can suggest a vaginal lubricant or moisturizer to help make sexual intercourse pain-free. "We look at various combinations of things we can do," Derzko said.

Bringing the partner in on the discussion is valuable, she added, because men often fear they will hurt their partner if sex is painful.

For libido and body image issues, Derzko said a woman might consider psychological therapy, ideally with someone trained in sexual issues and body image concerns.

And women who want a satisfying sex life shouldn't think of themselves as frivolous, she said. Some women think they should be thankful just to be alive and not complain about sexual functioning, she said.

But she said she tells them: "This is a part of wellness."

SOURCES: Mary Panjari, Ph.D., researcher, Women's Health Program, Monash University Medical School, Prahran, Victoria, Australia; Christine Derzko, M.D., associate professor of obstetrics and gynecology and internal medicine, St. Michael's Hospital, University of Toronto, Ontario, Canada; Sept. 23, 2010, online,Journal of Sexual Medicine

HealthDay

source: Medline Plus

Read More

Sexual Problems in Women

There are many problems that can keep a woman from enjoying sex. They include

• Lack of sexual desire
• Inability to become aroused
• Lack of orgasm, or sexual climax
• Painful intercourse

These problems may have physical or psychological causes. Physical causes may include conditions like diabetes, heart disease, nerve disorders or hormone problems. Some drugs can also affect desire and function. Psychological causes may include work-related stress and anxiety. They may also include depression or concerns about marriage or relationship problems. For some women, the problem results from past sexual trauma.

Occasional problems with sexual function are common. If problems last more than a few months or cause distress for you or your partner, you should see your healthcare provider.

Your sexual Health

source :Medline Plus

Read More

Male Menopause: Fact or Fiction?

An upsurge in media attention recently regarding the so-called "male menopause" has left many men rushing to their doctor to treat symptoms they believe may be related tolow levels of testosterone. The concept behind the concept of male menopause is that the decline in testosterone levels that occurs as men age may produce a characteristic and potentially treatable set of symptoms. Male menopause is also commonly referred to as low-T, andropause, or its medical name, late-onset hypogonadism.

However, some medical experts argue that the analogy to the process in women (with some authors even using terminology like "male PMS") has been carried too far. While it is true that testosterone levels do decline as a man ages, the decline in female hormones occurs to a much greater extent. Moreover, the symptoms in women associated with decreased estrogen levels are clearly understood.

In contrast, symptoms of what is referred to as male menopause are less clearly defined. Sexual dysfunction is a common complaint, but other nonspecific symptoms such as depression, mood changes, weight gain, or fatigue, have been interpreted by some as symptoms of a male midlife change. Although many doctors have treated midlife symptoms in men with testosterone hormone therapy, the value of male hormone therapy remains controversial because there are few long-term studies about the effects or benefits of testosterone supplementation.

Still, prescriptions for testosterone are on the rise, even if doctors don't yet agree on whether or not this therapy should be recommended.

In 2006, the Endocrine Society published evidence-based guidelines for testosterone replacement therapy in men. Specifically, for men who do not have testicular or pituitary disease, these experts recommend testosterone therapy only for men with definite and reproducibly low serum testosterone concentrations (<200 ng/dL) who have symptoms of androgen deficiency (symptoms of deficient blood levels of testosterone hormone).

As with any therapy, doctors will discuss the uncertainty about the risks and benefits of testosterone therapy. Experts further recommend that the therapeutic goal in these men is to reach a testosterone level that is lower than that for younger men, for example, 300 to 400 ng/dL, rather than 500 to 600 ng/dL, to minimize the potential risk of developing any testosterone-dependent diseases.

REFERENCE: Bhasin, S, Cunningham, GR, Hayes, FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2006; 91:1995.

SOURCE : http://www.medicinenet.com/script/main/art.asp?articlekey=119561

Read More